Chinese(GB)     
Contact CFDA
   
HOME ABOUT CFDA WHAT'S NEW LAWS & REGULATIONS REGULATORY GUIDE DATA SEARCH SITE MAP
  Search      
Home >> What's New  
What's New
SFDA issues Opinions on Deepening Drug Evaluation and Approval Reform and Further Encouraging Drug Innovation
2013-02-28
The State Food and Drug Administration (SFDA) recently issued the Opinions on Deepening Drug Evaluation and Approval Reform and Further Encouraging Drug Innovation. Focusing on the aspects of changing the evaluation concept for innovative drugs, adjusting the evaluation strategy for generic drugs, strengthening quality management for drug clinical trials and encouraging the research and development of children’s drugs, the Opinions aims at deepening reform, encouraging innovation and using the limited evaluation resources mainly in the evaluation of innovative drugs with clinical value and generic drugs urgently needed in clinical treatment.
HOME | ABOUT CFDA | WHAT'S NEW | LAWS AND REGULATIONS | REGULATORY GUIDE | DATA SEARCH
| SITE MAP |
© CFDA
Constructed and Maintained by the Information Center of CFDA